VAD

TSA recognizes top performers and airports of 2023

Retrieved on: 
Tuesday, April 30, 2024
TSA, Intelligence, Amber, Attitude, Transport, Safety, Mentorship, Character, Social media, Section, Triage, American Cancer Society, Conference, Female, Austin Police Department, Duty, Life, ACS, Injury, Communes of Burundi, Department of transportation, Professional, Workforce, Austin–Bergstrom International Airport, Los Angeles International Airport, Memory, Airport, Federal Air Marshal Service, Relay For Life, Coast guard, Airline

Honoring the memory, service and sacrifice of TSA Officer Gerardo Hernandez, this award recognizes employees who distinguish themselves through bravery, valor and heroism in the line of duty.

Key Points: 
  • Honoring the memory, service and sacrifice of TSA Officer Gerardo Hernandez, this award recognizes employees who distinguish themselves through bravery, valor and heroism in the line of duty.
  • The 2023 award recognizes Amanda Houck from Intelligence and Analysis.
  • The team also proactively conducted media events at 107 airports and earned coverage for airports of all sizes, including Guam, Saipan and Puerto Rico.
  • This award recognizes TSA employees who volunteer with nonprofit or community service programs or activities, contributing to meaningful results for individuals or the larger public good.

Breakthrough Cardiac Study Reveals Long-Term Impact on Post-Transplant Survival: A 2-Year Clinical Investigation Advancing Heart Preservation

Retrieved on: 
Friday, April 12, 2024
Health, Surgery, Clinical Trials, Medical Devices, Mortality, MCS, Ice, Hospital, Heart, Survival, Transport, Heart transplantation, Transplant, Patient, ECMO, Massachusetts General Hospital, Dentistry

Notably, the unprecedented study represents the first time any medical device technology has ever demonstrated statistically significant improvements in 2-year survival following heart transplantation.

Key Points: 
  • Notably, the unprecedented study represents the first time any medical device technology has ever demonstrated statistically significant improvements in 2-year survival following heart transplantation.
  • “This breakthrough is game-changing," said Dr. Scott Silvestry, a lead investigator and renowned cardiac surgeon with decades of clinical experience.
  • “This study indicates that the SherpaPak System can attenuate the risks of ischemic time through controlled hypothermic and isobaric preservation.
  • The intended organ storage time for the Paragonix SherpaPak™ Cardiac Transport System is up to 4 hours.

MediaTek Vice Chairman and CEO Dr. Rick Tsai to Deliver Keynote Speech at COMPUTEX 2024

Retrieved on: 
Tuesday, April 16, 2024
Android, AI, Chromebook, Silicon, Wi-Fi, Transport, Television, Smartphone, COMPUTEX, Byton (company), MediaTek, Socs, Medical device

TAIPEI, April 16, 2024 /PRNewswire/ -- TAITRA (Taiwan External Trade Development Council) has announced that Dr. Rick Tsai, Vice Chairman and CEO of MediaTek, will be a keynote speaker at COMPUTEX 2024 on June 4.

Key Points: 
  • TAIPEI, April 16, 2024 /PRNewswire/ -- TAITRA (Taiwan External Trade Development Council) has announced that Dr. Rick Tsai, Vice Chairman and CEO of MediaTek, will be a keynote speaker at COMPUTEX 2024 on June 4.
  • Dr. Tsai will explore how the latest silicon advancements and connectivity standards are making AI ubiquitous.
  • Dr. Tsai will share how generative AI will continue to transform mobility, transportation, the smart home, enterprises, and industrial environments in the future.
  • COMPUTEX 2024 with the theme "Connecting AI," is set to take place from June 4th to June 7th.

Particles for Humanity Completes Study Confirming No Major Difference in Taste or Smell of Bouillon and Broth with PFH-VAP

Retrieved on: 
Tuesday, April 2, 2024
Consumer, Taste, Vitamin, Humanity, Bill, Humidity, Smell, Vitamin A, Mineral, Multimedia, Vitamin A deficiency, Mulago Foundation, Dietary supplement

CAMBRIDGE, Mass., April 2, 2024 /PRNewswire/ -- Particles for Humanity has completed a study showing no major difference between the taste and smell of bouillon cubes containing the company's lead product, a stable form of vitamin A, called PFH-VAP.

Key Points: 
  • CAMBRIDGE, Mass., April 2, 2024 /PRNewswire/ -- Particles for Humanity has completed a study showing no major difference between the taste and smell of bouillon cubes containing the company's lead product, a stable form of vitamin A, called PFH-VAP.
  • One reason that food fortification is effective at addressing micronutrient deficiencies is because it does not require consumer behavior change.
  • The inclusion of PFH-VAP did not cause any major differences in taste or smell for cubes stored at either mild or harsh conditions.
  • Particles for Humanity transforms early-stage medical technology into products for people living in low and lower-middle income countries.

Infusion Nurses Society Adds Vascular Access Safety Devices Such as the Orchid SRV to Standard of Care Guidelines

Retrieved on: 
Tuesday, February 27, 2024
Biotechnology, Nursing, Managed Care, General Health, Health, Medical Devices, Hospitals, Health Technology, Hospital, BSN, Therapy, Doctor of Philosophy, RN, Orchid, Intravenous therapy, INS, Delirium, Confusion, Standard of care, Risk, Outline of health sciences, Safety, VADS, Deficit spending, Gold, Patient, Dementia, Veterans' affairs, Medical device

Linear Health Sciences , a medical device company that has developed a proprietary, breakaway safety valve platform, today announced that the Infusion Nurses Society (INS) has updated its standard of care to encompass devices designed to reduce the risk of vascular access device (VAD) dislodgement, including the Orchid SRV tension-activated breakaway safety release valve.

Key Points: 
  • Linear Health Sciences , a medical device company that has developed a proprietary, breakaway safety valve platform, today announced that the Infusion Nurses Society (INS) has updated its standard of care to encompass devices designed to reduce the risk of vascular access device (VAD) dislodgement, including the Orchid SRV tension-activated breakaway safety release valve.
  • The guidelines also flag pediatric patients and those with cognitive issues such as delirium or dementia as being at increased risk for IV dislodgement.
  • The Orchid SRV is a sterile, single-use connector for needle-free access that makes return to treatment fast, simple, and clean, and improves both the patient and clinician experience.
  • Clinical simulation testing of 360 Orchid SRVs showed that the device prevented IV dislodgement by 91.9 percent across all test groups.

ESI Expands into the B2B and Hospitality Markets

Retrieved on: 
Friday, March 8, 2024
ESI, B2B, VAN, EVP

VAN NUYS, Calif., March 7, 2024 /PRNewswire/ -- ESI, a global distributor, announces its expansion into the B2B and Hospitality Markets.

Key Points: 
  • VAN NUYS, Calif., March 7, 2024 /PRNewswire/ -- ESI, a global distributor, announces its expansion into the B2B and Hospitality Markets.
  • ESI works directly with manufacturers to distribute their products to Hotels, Casinos, Value Added Distributors (VAD's) and Employee Gifting Programs.
  • Tyler Asherian, ESI's EVP, stated, "As many companies are looking to decrease spending, ESI leverages our long-standing vendor relationships to offer pricing that provides our customers significant savings.
  • As brands struggle to offload their Excess or End-Of-Life Inventory, we found that distributing these products into the B2B market has positively impacted the brands' bottom lines as they are able to focus on their newer products instead of the previous generations."

Particles for Humanity Receives Approval to Begin a Study of PFH-VAP in Humans

Retrieved on: 
Tuesday, December 12, 2023
Vitamin A, Institutional review board, Research, IRB, Mineral, Mulago Foundation, Pregnancy, Principal investigator, University of Wisconsin–Madison, Bill, Multimedia, Malnutrition, Vitamin A deficiency, Humanity, Vitamin, University, Human, Tropical disease, Dietary supplement

The study is designed to confirm that PFH-VAP's improved stability enables more vitamin A to be delivered into the human body after consumption.

Key Points: 
  • The study is designed to confirm that PFH-VAP's improved stability enables more vitamin A to be delivered into the human body after consumption.
  • Particles for Humanity has partnered with the University of Wisconsin-Madison and the Tropical Diseases Research Centre in Zambia to conduct the study as part of its effort to combat vitamin A deficiency (VAD).
  • VAD is a devastating public health problem affecting 190 million children and 19 million pregnant women worldwide.
  • Particles for Humanity transforms early-stage medical technology into products for people living in low and lower-middle income countries.